{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:27:15Z","timestamp":1762918035544,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Science & Justice"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.scijus.2019.08.001","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T19:27:38Z","timestamp":1565724458000},"page":"86-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Development of a specific fragmentation pattern-based quadrupole-Orbitrap\u2122 mass spectrometry method to screen drugs in illicit products"],"prefix":"10.1016","volume":"60","author":[{"given":"Ji Hyun","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han Na","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam Sook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seongsoo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Moon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoil","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.scijus.2019.08.001_bb0005","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11419-016-0335-8","article-title":"Changes in dopamine, serotonin and their metabolites in brain microdialysates from rats following exposure to new psychoactive drugs","volume":"35","author":"Kim","year":"2017","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.scijus.2019.08.001_bb0010","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00787-016-0900-z","article-title":"Predictors of non-drug psychiatric\/psychotherapeutic treatment in children and adolescents with mental or behavioural disorders","volume":"26","author":"Abbas","year":"2017","journal-title":"Eur. Child Adolesc. Psychiatry"},{"author":"UNODC","key":"10.1016\/j.scijus.2019.08.001_bb0015"},{"key":"10.1016\/j.scijus.2019.08.001_bb0020","first-page":"1577","article-title":"A practical approach to avoiding cardiovascular adverse effects of psychoactive medications","volume":"32","author":"Brouillette","year":"2017","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.scijus.2019.08.001_bb0025","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/bja\/83.4.637","article-title":"Adverse effects of cannabis and cannabinoids","volume":"83","author":"Ashton","year":"1999","journal-title":"Br. J. Anaesth."},{"author":"UNODC","key":"10.1016\/j.scijus.2019.08.001_bb0030"},{"key":"10.1016\/j.scijus.2019.08.001_bb0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11419-013-0213-6","article-title":"Synthetic cannabinoids abused in South Korea: drug identifications by the National Forensic Service from 2009 to June 2013","volume":"32","author":"Chung","year":"2014","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.scijus.2019.08.001_bb0040","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jpba.2017.11.024","article-title":"Rapid and simple procedure for the determination of cathinones, amphetamine-like stimulants and other new psychoactive substances in blood and urine by GC-MS","volume":"149","author":"Mercieca","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.scijus.2019.08.001_bb0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.scijus.2016.08.007","article-title":"Indirect chiral separation of 8 novel amphetamine derivatives as potential new psychoactive compounds by GC\u2013MS and HPLC","volume":"57","author":"Wei","year":"2017","journal-title":"Sci. Justice"},{"key":"10.1016\/j.scijus.2019.08.001_bb0050","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1373\/clinchem.2009.135517","article-title":"Automated mass spectral deconvolution and identification system for GC-MS screening for drugs, poisons, and metabolites in urine","volume":"56","author":"Meyer","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.scijus.2019.08.001_bb0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.foodchem.2017.10.005","article-title":"Simultaneous LC-MS\/MS determination of 40 legal and illegal psychoactive drugs in breast and bovine milk","volume":"245","author":"Lopez-Garcia","year":"2018","journal-title":"Food Chem."},{"key":"10.1016\/j.scijus.2019.08.001_bb0060","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1007\/s00216-014-7763-2","article-title":"Validation of a multi-analyte LC-MS\/MS method for screening and quantification of 87 psychoactive drugs and their metabolites in hair","volume":"406","author":"Fisichella","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.scijus.2019.08.001_bb0065","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/dta.1948","article-title":"An LC-MS\/MS methodological approach to the analysis of hair for amphetamine-typestimulant (ATS) drugs, including selected synthetic cathinones and piperazines","volume":"9","author":"Lendoiro","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.scijus.2019.08.001_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2014.08.039","article-title":"Simple and sensitive screening and quantitative determination of 88 psychoactive drugs and their metabolites in blood through LC\u2013MS\/MS: Applicationon postmortem samples","volume":"970","author":"Sempio","year":"2014","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.scijus.2019.08.001_bb0075","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/0025802413477396","article-title":"Screening for synthetic cannabinoids in hair by using LC-QTOF MS: a new and powerful approach to study the penetration of these new psychoactive substances in the population","volume":"54","author":"Gottardo","year":"2014","journal-title":"Med. Sci. Law"},{"key":"10.1016\/j.scijus.2019.08.001_bb0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.forsciint.2017.12.001","article-title":"Quantitative analysis of drugs in hair by UHPLC high resolution mass spectrometry","volume":"283","author":"Kronstrand","year":"2018","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.scijus.2019.08.001_bb0085","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/jat\/bkw027","article-title":"Simultaneous analysis of cannabinoid and synthetic cannabinoids in dietary supplements using UPLC with UV and UPLC\u2013MS-MS","volume":"40","author":"Heo","year":"2016","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.scijus.2019.08.001_bb0090","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/19440049.2015.1040080","article-title":"Development and validation of an LC-MS\/MS method for the simultaneous analysis of 28 specific narcotic adulterants used in dietary supplements","volume":"32","author":"Choi","year":"2015","journal-title":"Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess."},{"key":"10.1016\/j.scijus.2019.08.001_bb0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11419-016-0331-z","article-title":"Identification of new synthetic cannabinoid analogue APINAC (adamantan-1-yl 1-pentyl-1H-indazole-3-carboxylate) with other synthetic cannabinoid MDMB(N)-Bz-F in illegal products","volume":"35","author":"Lee","year":"2017","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.scijus.2019.08.001_bb0100","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.scijus.2018.07.003","article-title":"Isolation and characterisation of a novel sildenafil analogue adulterant, desmethylpiperazinyl propoxysildenafil, in a dietary supplement","volume":"58","author":"Lee","year":"2018","journal-title":"Sci. Justice"},{"year":"2005","series-title":"Harmonized Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2(R1)","author":"(ICH) International Conference on Harmonization","key":"10.1016\/j.scijus.2019.08.001_bb0105"},{"key":"10.1016\/j.scijus.2019.08.001_bb0110","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.neuron.2014.01.016","article-title":"Enhancement of inhibitory neurotransmission by GABAA receptors having \u03b12,3-subunits ameliorates behavioral deficits in a mouse model of autism","volume":"81","author":"Han","year":"2014","journal-title":"Neuron."},{"key":"10.1016\/j.scijus.2019.08.001_bb0115","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/wps.20567","article-title":"Management of common adverse effects of antipsychotic medications","volume":"17","author":"Stroup","year":"2018","journal-title":"World Psychiatry"},{"key":"10.1016\/j.scijus.2019.08.001_bb0120","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0272-0590(89)90059-6","article-title":"Absence of liver DNA fragmentation in rats treated with high oral doses of 32 benzodiazepine drugs","volume":"12","author":"Carlo","year":"1989","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.scijus.2019.08.001_bb0125","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/dta.1526","article-title":"Simultaneous ESI-APCI(+) ionization and fragmentation pathways for nine benzodiazepines and zolpidem using single quadrupole LC-MS","volume":"6","author":"Galaon","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.scijus.2019.08.001_bb0130","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/mas.20332","article-title":"Fragmentation of toxicologically relevant drugs in positive-ion liquid chromatography\u2013tandem mass spectrometry","volume":"30","author":"Niessen","year":"2011","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.scijus.2019.08.001_bb0135","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1002\/rcm.3084","article-title":"Gas-phase fragmentation of protonated benzodiazepines","volume":"21","author":"Risoli","year":"2007","journal-title":"Rapid Commun. Mass Sp."},{"key":"10.1016\/j.scijus.2019.08.001_bb0140","first-page":"27","article-title":"Analysis of synthetic cannabinoids in botanical material: a review of analytical methods and findings","volume":"25","author":"Presley","year":"2013","journal-title":"Forensic Sci. Rev."},{"key":"10.1016\/j.scijus.2019.08.001_bb0145","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.talanta.2015.04.044","article-title":"Rapid analysis of synthetic cannabinoids using a miniature mass spectrometer with ambient ionization capability","volume":"142","author":"Ma","year":"2015","journal-title":"Talanta."},{"key":"10.1016\/j.scijus.2019.08.001_bb0150","doi-asserted-by":"crossref","first-page":"6301","DOI":"10.1007\/s00216-015-8612-7","article-title":"Identification and analytical characteristics of synthetic cannabinoids with an indazole-3-carboxamide structure bearing a N-1-methoxycarbonylalkyl group","volume":"407","author":"Shevyrin","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.scijus.2019.08.001_bb0155","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40263-017-0410-7","article-title":"Cardiovascular effects of stimulant and non-stimulant medication for children and adolescents with ADHD: a systematic review and meta-analysis of trials of methylphenidate, amphetamines and atomoxetine","volume":"31","author":"Hennissen","year":"2017","journal-title":"CNS Drugs."},{"author":"UNODC","key":"10.1016\/j.scijus.2019.08.001_bb0160"},{"key":"10.1016\/j.scijus.2019.08.001_bb0165","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","year":"2015","journal-title":"Lancet."},{"key":"10.1016\/j.scijus.2019.08.001_bb0170","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12916-016-0735-y","article-title":"Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review","volume":"14","author":"Onakpoya","year":"2016","journal-title":"BMC Med."},{"key":"10.1016\/j.scijus.2019.08.001_bb0175","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/15563650.2011.572076","article-title":"The clinical toxicology of the designer \"party pills\" benzylpiperazine and trifluoromethylphenylpiperazine","volume":"49","author":"Schep","year":"2011","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.scijus.2019.08.001_bb0180","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/318148","article-title":"Fragmentation pathways of trifluoroacetyl derivatives of methamphetamine, amphetamine, and methylendioxyphenylalkylamin designer drugs by gas chromatography\/mass spectrometry","volume":"2011","author":"Kumazawa","year":"2011","journal-title":"Int. J. Spectrosc."},{"key":"10.1016\/j.scijus.2019.08.001_bb0185","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/jms.1731","article-title":"Hydride transfer reactions via ion\u2013neutral complex: fragmentation of protonated N-benzylpiperidines and protonated N-benzylpiperazines in mass spectrometry","volume":"45","author":"Chai","year":"2010","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.scijus.2019.08.001_bb0190","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.forsciint.2018.08.028","article-title":"Identification and characterization of an indazole-3-carboxamide class synthetic cannabinoid: 2-[1-(cyclohexylmethyl)-1H-indazole-3- carboxamido]-3,3-dimethylbutanoic acid (DMBA-CHMINACA)","volume":"291","author":"Lee","year":"2018","journal-title":"Forensic Sci. Int."}],"container-title":["Science & Justice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1355030619300632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1355030619300632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:46:45Z","timestamp":1761180405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1355030619300632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1355030619300632"],"URL":"https:\/\/doi.org\/10.1016\/j.scijus.2019.08.001","relation":{},"ISSN":["1355-0306"],"issn-type":[{"type":"print","value":"1355-0306"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a specific fragmentation pattern-based quadrupole-Orbitrap\u2122 mass spectrometry method to screen drugs in illicit products","name":"articletitle","label":"Article Title"},{"value":"Science & Justice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scijus.2019.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Chartered Society of Forensic Sciences. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}